4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-21-009130
Chief Development Officer sold 4,546 shares at an average $116.33 ($528,857)
From the SEC's structured data for this filing
Trades in this filing
Bozigian Haig P. · Chief Development Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-05 | Sale : show line 1 in the form | −704 | $113.79 | $80,109 | 153,328 | D |
| 2021-02-08 | Sale : show line 2 in the form | −824 | $116.85 | $96,286 | 154,934 | D |
| 2021-02-08 | Sale : show line 3 in the form | −1,395 | $116.78 | $162,912 | 156,189 | D |
| 2021-02-08 | Sale : show line 4 in the form | −1,623 | $116.79 | $189,550 | 157,651 | D |
| Open-market sales · 4,546 sh · avg $116.33 · $528,857 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-08 | Grant or award : show line 5 in the form Stock Option | +3,188 | 3,188 | D |
| 2021-02-08 | Grant or award : show line 6 in the form Restricted Stock Unit | +532 | 532 | D |
Loading xslF345X03/doc4.xml…